Salesforce
CRM
$259.43
+4.73%
Salesforce, Inc. is the world's leading enterprise cloud software company, providing Customer Relationship Management (CRM) technology through its integrated Customer 360 platform, which spans Sales Cloud, Service Cloud, Marketing Cloud, Commerce Cloud, the Salesforce Platform (including Slack and Tableau), and MuleSoft for data integration. As the dominant player in the CRM software market with roughly 83,000 employees and a market capitalization exceeding $200 billion, Salesforce is widely regarded as the anchor platform of the enterprise front-office software stack and a bellwether for the broader SaaS sector. The current investor narrative has shifted dramatically from the "SaaSpocalypse" fears that gripped the stock earlier in 2026 — when agentic AI was feared to commoditize seat-based software — toward a re-rating driven by blowout Q2 FY2027 results, a $25 billion accelerated share repurchase program, and a landmark partnership with Anthropic that converted a perceived AI threat into a growth catalyst. Debate now centers on whether the AI-driven reacceleration is durable, how much of the recent earnings beat was flattered by a $2.7 billion non-operating gain from Salesforce's Anthropic stake, and whether the stock's sharp August rally has already priced in the recovery.…
CRM
Salesforce
$259.43
Related headlines
Investment Opinion: Should I buy CRM Today?
Rating: Buy. Salesforce offers a compelling risk/reward proposition at current levels, anchored by a consensus analyst rating of 'buy' (mean 1.75 from 54 analysts) and an average price target of $273.37, implying 10.4% upside. The core thesis is that the Anthropic partnership has transformed a major AI threat into a growth catalyst, while the $25 billion buyback and a forward P/E of 15.47x provide a margin of safety. The recent 49% three-month rally reflects improving sentiment, but the stock remains undervalued relative to its historical multiples and long-term growth potential.
Supporting evidence includes: (1) revenue growth of 13.27% YoY in Q1 FY2027, with Q2 showing acceleration; (2) gross margin of 77.68% and operating margin of 21.47%, demonstrating strong profitability; (3) free cash flow of $14.66 billion TTM, funding the $25 billion buyback and a modest dividend yield of 0.79%; (4) forward P/E of 15.47x and PEG of 1.24, which are attractive for a company with Salesforce's market leadership and AI optionality. The buyback has reduced diluted shares by 10.6% year-over-year, providing a direct boost to EPS. Compared to the broader software sector, CRM's valuation is reasonable, especially given its dominant position in the $200+ billion CRM market.
Key risks that could invalidate the thesis include: (1) core growth decelerating below 10% as competition intensifies; (2) the Anthropic gain proving to be a one-time event, leading to disappointing future earnings; (3) a macroeconomic downturn compressing software multiples. The rating would upgrade to a strong buy if AI monetization accelerates and forward P/E remains below 18x, or downgrade to hold if revenue growth falls below 10% or if the stock approaches the analyst average target of $273 without fundamental improvement. At $247.72, the stock is fairly valued to slightly undervalued relative to its growth prospects and historical trading range.
Sign up to view all
CRM 12-Month Price Forecast
Salesforce presents a compelling investment case with a favorable risk/reward profile, supported by its dominant market position, attractive forward valuation, and strategic AI partnership with Anthropic. The stock's recent rally reflects improving fundamentals, but the forward P/E of 15.47x suggests the market is not fully pricing in the potential for AI-driven growth acceleration. The base case (55% probability) targets $260-290, aligning with the analyst average of $273.37, while the bull case (25%) could see $300-475 if AI monetization exceeds expectations. Key risks include competitive pressures and the sustainability of core growth, which could trigger a bear case (20%) down to $146-160. I would upgrade to high confidence if Q3 FY2027 results show accelerating revenue growth and margin expansion, and downgrade if growth decelerates below 10% or if AI contributions fail to materialize.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Salesforce's 12-month outlook, with a consensus price target around $273.37 and implied upside of +5.4% versus the current price.
Average Target
$273.37
0 analysts
Implied Upside
+5.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$160 - $475
Analyst target range
Drowning in data?
Find the real signal!
Bulls vs Bears: CRM Investment Factors
The bull case currently has stronger evidence, driven by the Anthropic partnership that neutralized the AI disruption narrative, a $25 billion buyback reducing share count by over 10%, and a forward P/E of just 15.47x that remains attractive despite the recent rally. However, the bear case raises valid concerns about the sustainability of earnings growth given the $2.7 billion one-time Anthropic gain and the stock's 49% three-month surge that may have already priced in much of the good news. The single most important tension is whether Salesforce's core AI monetization (Agentforce, Data Cloud) can deliver durable double-digit growth without relying on non-operating gains, which would justify the re-rating and support further upside toward the $273 average analyst target. If core growth decelerates or AI competition intensifies, the stock could retest its 52-week low of $146.32, representing 41% downside from current levels.
Bullish
- AI Threat Turned Partner: Salesforce's landmark partnership with Anthropic converted the biggest perceived AI disruption risk into a growth catalyst, and the company booked a $2.7 billion non-operating gain from its Anthropic stake in Q2 FY2027. This strategic pivot removes the existential 'SaaSpocalypse' narrative that had compressed the stock earlier in 2026 and opens a significant upsell opportunity for Agentforce and Data Cloud.
- Blowout Q2 FY2027 Earnings: Q1 FY2027 (quarter ended 2026-04-30) revenue grew 13.27% YoY to $11.13 billion with EPS of $2.43, while Q2 results triggered a 20%+ single-day surge on 2026-08-27. The stock has rallied 28.14% in the past month and 49.33% over three months, dramatically outperforming the S&P 500's -1.06% and 3.04% respective returns.
- Aggressive $25B Buyback: Salesforce's $25 billion accelerated share repurchase program is shrinking the share count — diluted shares fell from 974 million in Q4 FY2025 to 871 million in Q1 FY2027, a 10.6% reduction. This capital return strategy directly boosts EPS and signals management's confidence in the company's intrinsic value.
- Compelling Forward Valuation: At a forward P/E of just 15.47x and PEG ratio of 1.24, CRM trades at a significant discount to its historical software multiples and the broader SaaS sector. The trailing P/E of 27.04x and P/S of 4.86x also appear reasonable given the company's 77.68% gross margin and 21.47% operating margin.
Bearish
- Earnings Flattered by One-Time Gain: A significant portion of the Q2 FY2027 earnings beat was driven by a $2.7 billion non-operating gain from Salesforce's Anthropic stake, which is not recurring. Core business growth was a solid but less spectacular 16%, raising questions about the durability of the AI-driven reacceleration.
- Rich Valuation After Sharp Rally: The stock has surged 49.33% in three months and 28.14% in the past month, pushing the trailing P/E to 27.04x and EV/EBITDA to 16.08x. The sharp August rally may have already priced in much of the recovery, leaving limited margin of safety for new investors.
- Weak Balance Sheet Liquidity: Salesforce's current ratio of 0.76 indicates that current liabilities exceed current assets, a potential liquidity concern. While the company generates strong free cash flow ($14.66 billion TTM), the low current ratio could constrain financial flexibility in a downturn.
- Competitive Threats Intensify: Microsoft and ServiceNow are aggressively expanding their AI capabilities, as highlighted by ServiceNow's broadening Aramco AI partnership. Veeva's raised FY27 outlook on strong Vault CRM adoption also signals intensifying competition in core verticals, which could pressure Salesforce's market share and pricing power.
CRM Technical Analysis
Beta
1.20
1.20x market volatility
Max Drawdown
-43.6%
Largest decline past year
52-Week Range
$146-$269
Price range past year
Annual Return
+6.9%
Cumulative gain past year
| Period | CRM Return | S&P 500 |
|---|---|---|
| 1m | +32.2% | -2.0% |
| 3m | +60.4% | +1.4% |
| 6m | +33.5% | +15.0% |
| 1y | +6.9% | +15.7% |
| ytd | +2.3% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRM Fundamental Analysis
Quarterly Revenue
$11.1B
2026-04
Revenue YoY Growth
+13.3%
YoY Comparison
Gross Margin
76.9%
Latest Quarter
Free Cash Flow
$14.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRM Overvalued?
PE
27.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~247x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.1x
Enterprise Value Multiple
Investment Risk Disclosure
Salesforce faces financial and operational risks primarily from its reliance on non-recurring gains and a weak current ratio. The Q2 FY2027 earnings beat was significantly flattered by a $2.7 billion non-operating gain from its Anthropic stake, which is unlikely to repeat and could create difficult year-over-year comparisons. Additionally, the current ratio of 0.76 indicates that current liabilities exceed current assets, a potential liquidity concern despite strong free cash flow of $14.66 billion TTM. The company's debt-to-equity ratio of 0.29 is manageable, but the low current ratio warrants monitoring, especially if economic conditions tighten. Furthermore, revenue growth of 13.27% YoY, while solid, is a deceleration from historical levels, and any further slowdown could pressure the valuation.
Market and competitive risks are significant given Salesforce's premium valuation and intense competition. The stock trades at a trailing P/E of 27.04x and EV/EBITDA of 16.08x, which, while below historical peaks, still assumes continued growth and margin expansion. With a beta of 1.202, CRM is more volatile than the broader market, and its 1-year relative strength versus the S&P 500 is -15.64%, indicating underperformance over the longer term. Competition from Microsoft, ServiceNow, and Veeva is intensifying, as evidenced by ServiceNow's expanding AI partnership with Aramco and Veeva's raised FY27 outlook on strong Vault CRM adoption. These competitive threats could erode Salesforce's market share and pricing power, especially in key verticals.
The worst-case scenario for Salesforce would involve a combination of decelerating core growth, increased competition, and a broader market downturn that compresses software multiples. If AI monetization fails to materialize and the Anthropic gain proves to be a one-time event, the stock could retest its 52-week low of $146.32, representing a 41% decline from the current price of $247.72. The analyst low target of $160 implies a 35% downside, and the historical max drawdown of 43.61% suggests that such a decline is within the realm of possibility. In this adverse scenario, investors could lose 35-41% of their investment, underscoring the importance of position sizing and risk management.
FAQ
The key risks include: (1) Financial risk: the Q2 earnings beat was flattered by a $2.7 billion one-time Anthropic gain, and the current ratio of 0.76 indicates potential liquidity constraints; (2) Competitive risk: Microsoft, ServiceNow, and Veeva are intensifying competition in AI-powered CRM, which could pressure market share and pricing; (3) Macro risk: with a beta of 1.202, CRM is sensitive to market downturns, and software multiples could compress if interest rates rise; (4) Company-specific risk: the sustainability of AI monetization is unproven, and any disappointment could lead to a sharp re-rating. Ranked by severity, competitive and company-specific risks are the most immediate, followed by macro and financial risks.
Our 12-month forecast presents three scenarios: Bull case (25% probability) targets $300-475, driven by accelerated AI monetization and margin expansion; Base case (55% probability) targets $260-290, assuming steady 12-14% revenue growth and stable multiples; Bear case (20% probability) targets $146-160, reflecting decelerating growth and competitive pressures. The base case is most likely, anchored by the analyst average target of $273.37 and a forward P/E of 15.47x. The key assumption behind the base case is that Salesforce maintains low-teens growth and successfully integrates AI into its product suite without significant disruption. Investors should monitor Q3 FY2027 earnings for signs of acceleration or deceleration.
CRM appears fairly valued to slightly undervalued. The forward P/E of 15.47x is below the broader software sector average and significantly below CRM's historical peak multiples, while the PEG ratio of 1.24 suggests the stock is reasonably priced relative to its growth rate. The trailing P/E of 27.04x and P/S of 4.86x are moderate for a company with 77.68% gross margins and a dominant market position. Compared to peers like Microsoft (trading at a premium) and ServiceNow, CRM offers a discount despite similar growth prospects. The market appears to be pricing in mid-teens earnings growth, and any acceleration from AI monetization could drive multiple expansion.
From a risk/reward perspective, CRM appears to be a good buy for investors with a medium to long-term horizon. The stock trades at a forward P/E of 15.47x, which is attractive relative to its historical average and the broader software sector, and the analyst consensus target of $273.37 implies 10.4% upside. The biggest downside risk is a retest of the 52-week low of $146.32, representing 41% downside, but this would likely require a significant deterioration in fundamentals. The company's $25 billion buyback and strong free cash flow provide support. For investors comfortable with beta of 1.202 and seeking exposure to enterprise AI, CRM is a compelling buy at current levels, especially on pullbacks.
CRM is best suited for long-term investment, with a suggested minimum holding period of 2-3 years. The company is in a transition phase, shifting from a seat-based model to an AI-driven platform, and the full benefits of its Anthropic partnership and Agentforce investments will take time to materialize. The stock's beta of 1.202 and 43.61% max drawdown indicate significant volatility, making it less suitable for short-term trading unless one has a high risk tolerance. The dividend yield of 0.79% is modest, so total return will depend primarily on capital appreciation. Long-term investors can benefit from the $25 billion buyback, which reduces share count and boosts EPS over time. For short-term traders, the stock's high relative strength (29.2% vs. S&P 500 over 1 month) may offer momentum opportunities, but timing is critical.
